Abstract
Atrial fibrillation (AFib) represents a critical diagnostic challenge in clinical cardiology, calling for automated detection systems capable of robust performance across diverse clinical environments. We present a computationally efficient deep neural network architecture for AFib detection that demonstrates exceptional generalizability despite training on a modest dataset. Our convolutional neural network, comprising 17 million parameters, was trained on 67,432 12-lead electrocardiograms and subsequently validated on over 1.1 million ECG recordings spanning six independent public datasets. On CPU, the model processes a 10-second ECG in 200 ms, enabling real-time inference capabilities.
Our model achieves state-of-the-art performance, with an average area under the receiver operating characteristic curve (AUROC) of 0.97, an average sensitivity of 0.83, and an average specificity of 0.96 across six external validation cohorts. These metrics rank among the highest reported in the literature, while preserving computational efficiency suitable for resource-constrained environments.
A key innovation of our approach is the implementation of channel-masking methodology, enabling seamless operation across variable lead configurations without model retraining. This flexibility allows deployment from single-lead ambulatory monitors to comprehensive 12-lead clinical systems using identical network weights. Gradient-based saliency analysis confirms the model’s attention to physiologically relevant features, particularly P-wave morphology and lead II characteristics, thereby enhancing clinical interpretability and trustworthiness.
Our findings also establish that a single, well-curated small training dataset can yield a compact yet highly generalizable AFib detection system suitable for deployment across diverse clinical settings, from critical care monitoring to ambulatory screening applications. The combination of robust cross-dataset performance, computational efficiency, and clinical interpretability positions this approach as a viable solution for largescale AFib diagnosis and monitoring programs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email addresses: harshitmishra{at}gofynd.com (Harshit Mishra), nachiketmakwana{at}gofynd.com (Nachiket Makwana), drpradyot.tiwari{at}gmail.com. (Pradyot Tiwari), ksubramani9{at}hotmail.com (K. Subramani), hari{at}iisc.ac.in (K. V. S. Hari)
Data Availability
All data produced in the present work are contained in the manuscript
